# Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis

> **NCT00705978** · PHASE3 · COMPLETED · sponsor: **Abbott Products** · enrollment: 62 (actual)

## Conditions studied

- Pancreatic Insufficiency

## Interventions

- **DRUG:** Pancreatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00705978
- **Lead sponsor:** Abbott Products
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2011-08-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00705978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00705978, "Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00705978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*